The clinical pilot study for the evaluation of the efficacy and safety of Monascus-fermentation (Monascus-fermented black bean) on reducing body weight and serum total cholesterol obese subjects

Not Applicable

Completed

• Conditions: Not Applicable

• Registration Number: KCT0001040
• Lead Sponsor: Inje University Seoul Paik Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 11 March 2019

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

1) Male and female subjects between 20-65years of age inclusive.
2) BMI of 25.0-29.9kg/m2
3) Serum total cholesterol = 240mg/dl
4) Evidense of a personally signed and dated informed consent document indicating that the subject has been informed of all pertinent aspects of the trial.

Exclusion Criteria

1. Subjects with systolicBP = 160 mmHg or diastolicBP = 100 mmHg and also taking a beta blocker or a hydragogue.
2. Subjects with diabetes(use of hypoglycemic agent or insulin)or fasting blood glucose = 126 mg/dL or random blood glucose = 200 mg/dL.
3. Subjects who taking anti-hypercholesterolemia
4. Subjects with endocrinopathy or abnormal screening TSH value(=0.1uU/ml or =10 uU/ml).
5. Serum AST/ALT = 3 times the upper limit of normal.
6. Serum creatinine = 2 times the upper limit of normal.
7. Use of prescription drugs or supplements known to alter body weight or appetite, antidepressants, oral contraceptive, steroid, female sex hormon.
8. Subjects with clinically significant cardiovascular disease within the 6 months prior to screening.
9. Subjects with a history of cancer and intervention within the 5 years prior to screening.
10. Subjects with a history of CNS disorder(depressive disorder, schizophrenia, alcoholism, drug addiction).
11. Women of childbearing age who are disagreed with effective contraceptions in the clinical trial period.
12. Woman who are pregnant or lactating.
13. Participation in any clinical trial within the 3 months prior to screening.
14. Subjects who change weight over 10 percent within 3 months
15. Subjects with the musculoskeletal disorders or restricted physical activity.
16. Subjects who could affect preclude evaluation of response in the opinion investigator.

Study & Design

• Study Type: Interventional Study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Body weight ;Fat percentage(by DEXA) ;Fat mass(by DEXA) ;Serum total cholesterol

Secondary Outcome Measures

Name	Time	Method
Waist circumference